title: Local methotrexate injection: a nonsurgical treatment of ectopic pregnancy.
abstract: Twenty seven patients with unruptured tubal pregnancy were selected for nonsurgical treatment with the use of one injection of 12.5 mg of methotrexate into the ectopic site at laparoscopy. No adverse reactions were observed. In three patients (11%), a laparotomy was performed because of rising beta-human chorionic gonadotropin titers. In the other patients, serum beta-human chorionic gonadotropin levels decreased to the nonpregnant range with no further intervention, and the patients recovered uneventfully. This method is suggested as an alternative to surgery in selected cases of early unruptured tubal pregnancy.
authors: Department of Obstetrics and Gynecology, Assaf Harofe Medical Centre, Zerifin, Israel.
authors: M
authors: M
authors: Pansky
authors: I
authors: I
authors: Bukovsky
authors: A
authors: A
authors: Golan
authors: R
authors: R
authors: Langer
authors: D
authors: D
authors: Schneider
authors: S
authors: S
authors: Arieli
authors: E
authors: E
authors: Caspi
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human; D003131:Combined Modality Therapy; D005187:Fallopian Tubes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections / Q000379:methods; D010535:Laparoscopy; D008727:Methotrexate / Q000008:administration & dosage*; D010446:Peptide Fragments / Q000097:blood; D011184:Postoperative Period; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000097:blood / Q000188:drug therapy*
chemical_list: D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D008727:Methotrexate